Speaker Profile
Ph.D., MBA, Executive Chairman and CEO, Human Longevity
Biography
Wei-Wu He has been serving as Executive Chairman of Human Longevity Inc since July 2019. Prior to this role, he was the CEO of OriGene Technologies, Inc. He is also the founder and General Partner of Emerging Technology Partners, LLC (ETP), a life sciences–focused venture fund established in 2000. Throughout his career, Dr. He has been involved in the founding or funding of nearly 100 biotechnology companies spanning genomics, precision medicine, and emerging technologies. Earlier in his career, he was among the first few scientists at Human Genome Sciences and previously served as a research fellow at Massachusetts General Hospital and the Mayo Clinic. Dr. He is an accomplished inventor and author, with more than 30 peer-reviewed research publications and over 30 issued patents.
Talk
Wei-Wu will discuss how Human Longevitys new platform integrates genomic, imaging, and clinical data to enable earlier detection of cancer and other diseasesempowering individuals and clinicians to proactively identify risk, take informed preventive action, and support healthier aging.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
Epigenetic Rejuvenation & Delivery for Clinical Translation
• Chair: Ryan (Yuancheng) Lu, Whitehead Institute/MIT
• David Sinclair, Harvard
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Medicine
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform
• Wei-Wu He, Human Longevity
• Hussain Ahamed, Ultrahuman
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
• Michael Gurven, UC Santa Barbara
